Podcast Episodes

Back to Search
RLAY Stock's Phase 3 Threat to Big Pharma Oncology
RLAY Stock's Phase 3 Threat to Big Pharma Oncology

Relay Therapeutics (RLAY) targets 69% upside — Phase 3 biotech stock analysis & valuation.

👉 Want this level of research on ANY COMPANY IN THE WORLD.…

1 week, 3 days ago

Short Long
View Episode
NewtekOne's 6x P/E Hides a Disruptive Digital Bank
NewtekOne's 6x P/E Hides a Disruptive Digital Bank

NEWT stock analysis: bank pivot unlocks 6x P/E valuation — buy or sell deep dive

👉 Want this level of research on ANY COMPANY IN THE WORLD... for FRE…

1 week, 3 days ago

Short Long
View Episode
RUSHA’s Hidden 66% Profit Moat & 2026 EPA Catalyst
RUSHA’s Hidden 66% Profit Moat & 2026 EPA Catalyst

RUSHA stock analysis: 2027 EPA rules trigger massive truck pre-buy — buy or sell?

👉 Want this level of research on ANY COMPANY IN THE WORLD... for FR…

1 week, 3 days ago

Short Long
View Episode
HelloFresh (HFG) 95% Crash Masks Positive Cash Flow
HelloFresh (HFG) 95% Crash Masks Positive Cash Flow

HelloFresh (HFG) stock analysis: down 95% from peak — asymmetric valuation breakdown

👉 Want this level of research on ANY COMPANY IN THE WORLD... for…

1 week, 3 days ago

Short Long
View Episode
MKTW: The GAAP Disconnect Masking 15% Cash Growth
MKTW: The GAAP Disconnect Masking 15% Cash Growth

MarketWise (MKTW) reveals a 15% billings surge — the ultimate turnaround stock analysis.

👉 Want this level of research on ANY COMPANY IN THE WORLD...…

1 week, 3 days ago

Short Long
View Episode
SNAP $500M Layoffs and the Activist Turnaround Gamble
SNAP $500M Layoffs and the Activist Turnaround Gamble

Snap Inc (SNAP) cuts $500M in overhead — buy or sell? Full stock analysis & valuation.

👉 Want this level of research on ANY COMPANY IN THE WORLD... f…

1 week, 3 days ago

Short Long
View Episode
OFG Bancorp's 26% Earnings Beat Exposes a 9.9x P/E
OFG Bancorp's 26% Earnings Beat Exposes a 9.9x P/E

OFG stock analysis: 5.36% NIM crushes mainland peers — full valuation deep dive

👉 Want this level of research on ANY COMPANY IN THE WORLD... for FREE…

1 week, 3 days ago

Short Long
View Episode
SEPN Oral GPCR Pipeline Threatens $7B Injectables
SEPN Oral GPCR Pipeline Threatens $7B Injectables

Septerna (SEPN) secures $522M & Novo validation — biotech stock analysis & valuation

👉 Want this level of research on ANY COMPANY IN THE WORLD... for…

1 week, 3 days ago

Short Long
View Episode
JRVR Activist Breakup at 0.45x Tangible Book
JRVR Activist Breakup at 0.45x Tangible Book

JRVR valuation breakdown: trades at 0.45x book value — a massive activist catalyst

👉 Want this level of research on ANY COMPANY IN THE WORLD... for F…

1 week, 3 days ago

Short Long
View Episode
IIIN's 22% crash ignores a $550B infrastructure moat
IIIN's 22% crash ignores a $550B infrastructure moat

Insteel (IIIN) reveals 37% cyclical upside — full valuation deep dive & stock analysis

👉 Want this level of research on ANY COMPANY IN THE WORLD... f…

1 week, 3 days ago

Short Long
View Episode

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us